Liraglutide
- Level
- Commodity
- Parent
- 51183600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51183611This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 839I73S42A. European Medicines Agency schedules Liraglutide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25238. Liraglutide generally arises in the molecular formula C172H265N43O51. The term LIRAGLUTIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 17, no. 2uy, 2003, list 49.) Most nations, for tariff and trade purposes, schedule liraglutide under HS 29371900 and SITC 54154. As of Q4 2014, LIRAGLUTIDE remains US FDA's Preferred Term for this commodity. Liraglutide bears US NLM identifiers UMLS ID C1456408 and NCI Concept Code C82239. SMILES: CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)O)C(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N.
Same parent
Under 51183600 · 22Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.